Literature DB >> 9164925

Correlation of tolerogenicity of a viral antigen with its immunogenicity.

M F Bachmann1, T Fehr, G Freer, H Hengartner, R M Zinkernagel.   

Abstract

Induction of B cell tolerance or activation was analyzed with vesicular stomatitis virus (VSV) glycoprotein (G) expressed as a neo-self Ag. A membrane form of VSV-G expressed in all tissues, including the bone marrow, induced unresponsiveness at both the Th and B cell level, whereas a soluble form of VSV-G expressed peripherally in liver and kidney did not tolerize B cells and only reversibly anergized Th cells. Interestingly, a similar correlation was found for activation of mature lymphocytes. When mature normal spleen cells were transferred into the two transgenic mouse lines, the membrane form of VSV-G was strongly immunogenic for both Th and B cells, and high VSV-G-specific IgG Ab titers were induced in these transgenic mice. In contrast, spleen cells transferred into mice expressing the soluble form of VSV-G were not activated, and no VSV-G specific Abs were induced. These results indicate that highly immunogenic Ags are strongly tolerogenic for both immature B and T cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9164925

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Evidence for intermolecular domain exchange in the Fab domains of dimer and oligomers of an IgG1 monoclonal antibody.

Authors:  Yin Luo; Stephen W Raso; Judith Gallant; Colleen Steinmeyer; Yasuko Mabuchi; Zhaojiang Lu; Clifford Entrican; Jason C Rouse
Journal:  MAbs       Date:  2017-06-07       Impact factor: 5.857

2.  Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice.

Authors:  A Ciurea; P Klenerman; L Hunziker; E Horvath; B Odermatt; A F Ochsenbein; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

Review 3.  Neutralizing antiviral antibody responses.

Authors:  R M Zinkernagel; A LaMarre; A Ciurea; L Hunziker; A F Ochsenbein; K D McCoy; T Fehr; M F Bachmann; U Kalinke; H Hengartner
Journal:  Adv Immunol       Date:  2001       Impact factor: 3.543

4.  Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19.

Authors:  T Fehr; R C Rickert; B Odermatt; J Roes; K Rajewsky; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.